BLOG

Wednesday, April 15, 2020

How 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy

An analysis of more than 10,000 gliomas and clinical outcomes found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.

from Top Health News -- ScienceDaily https://ift.tt/34Lwcy7
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...